Finance

Lists
OKYO:NASDAQ
OKYO Pharma Ltd
US$ १.४३
-०.६९%
(-०.०१०) 1D
अक्टोबर १३, १४:४३:०६ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKYO...
Open
US$ १.४६
High
US$ १.४७
Low
US$ १.४१
Mkt. cap
७.५० करोड
Avg. vol.
७४.१३ हजार
Volume
१५.७९ हजार
52-wk high
US$ ३.२०
52-wk low
US$ १.२६
EPS
-US$ ०.३२
Beta
-०.०३
Shares outstanding
५.२५ करोड
No. of employees
५
Open
US$ १.४६
High
US$ १.४७
Low
US$ १.४१
Mkt. cap
७.५० करोड
Avg. vol.
७४.१३ हजार
Volume
१५.७९ हजार
52-wk high
US$ ३.२०
52-wk low
US$ १.२६
EPS
-US$ ०.३२
Beta
-०.०३
Shares outstanding
५.२५ करोड
No. of employees
५
News stories
From web sources and news partners
MarketBeat
MarketBeat
·
४ मिनेट पहिले
Varonis Systems (NASDAQ:VRNS) Shares Climb 5.4% on Analyst Upgrade
Timothy Sykes
Timothy Sykes
·
२७ मिनेट पहिले
SCNI Regains Nasdaq Compliance As Traders Reassess Risk
Seeking Alpha
Seeking Alpha
·
१ घण्टा पहिले
Mentions of inflation have ballooned for tech companies – SoFi (SP500:)
Bloomberg.com
Bloomberg.com
·
४ घण्टा पहिले
S&P 500 Record Rally Meets Risk of Peaking Earnings Growth
About OKYO Pharma Ltd
CEO-
Employees५
Founded२००७
Headquartersलण्डन, इङ्ल्यान्ड, संयुक्त अधिराज्य
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to OKYO in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for OKYO in the last 3 months.
Highest
Current US$ १.४३
US$ ७.०० (+३८९.५१%)
Average
US$ ६.०० (+३१९.५८%)
Lowest
US$ ५.०० (+२४९.६५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
US$ ५.००
+२४९.७%
10/06/2026
Biren Amin
Piper Sandler
Buy
Maintained
US$ ७.००
+३८९.५%
08/27/2026
William Wood
B. Riley Securities
Buy
Initiated
US$ ५.००
+२४९.७%
12/08/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
-
-
-
-
Cost of goods sold
१२.७३ लाख
१२.७३ लाख
२०.७२ लाख
२०.७२ लाख
Cost of revenue
१२.७३ लाख
१२.७३ लाख
२०.७२ लाख
२०.७२ लाख
Research and development expenses
-२२.०२ हजार
-२२.०२ हजार
९.२७ लाख
९.२७ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-२२.०२ हजार
-२२.०२ हजार
९.२७ लाख
९.२७ लाख
Total operating expenses
१२.५१ लाख
१२.५१ लाख
२९.९९ लाख
२९.९९ लाख
Operating income
-१२.५१ लाख
-१२.५१ लाख
-२९.९९ लाख
-२९.९९ लाख
Other non operating income
-
-
-१४०.००
-१४०.००
EBT including unusual items
-१२.९३ लाख
-१२.९३ लाख
-३१.७७ लाख
-३१.७७ लाख
EBT excluding unusual items
-१२.९३ लाख
-१२.९३ लाख
-३१.७७ लाख
-३१.७७ लाख
Income tax expense
२६.००
२६.००
३.९७ हजार
३.९७ हजार
Effective tax rate
-
-
-०.१२%
-०.१२%
Other operating expenses
-
-
-
-
Net income
-१२.९३ लाख
-१२.९३ लाख
-३१.८१ लाख
-३१.८१ लाख
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
१६.०५ हजार
१६.०५ हजार
Interest expense
-४२.२९ हजार
-४२.२९ हजार
-१.९५ लाख
-१.९५ लाख
Net interest expenses
-४२.२९ हजार
-४२.२९ हजार
-१.७९ लाख
-१.७९ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१२.५१ लाख
-१२.५१ लाख
-२९.९८ लाख
-२९.९८ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू